Stock Price Quote

CAMLIN FINE SCIENCES LTD.

NSE : CAMLINFINEBSE : 532834ISIN CODE : INE052I01032Industry : ChemicalsHouse : S Dandekar
BSE138.25-0.55 (-0.4 %)
PREV CLOSE ( ) 138.80
OPEN PRICE ( ) 140.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 190279
TODAY'S LOW / HIGH ( )136.80 146.70
52 WK LOW / HIGH ( )96.3 334.7
NSE138.47-0.17 (-0.12 %)
PREV CLOSE( ) 138.64
OPEN PRICE ( ) 140.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 138.47 (3210)
VOLUME 2154028
TODAY'S LOW / HIGH( ) 136.36 146.50
52 WK LOW / HIGH ( )96.21 333.3
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 30-11 1993
Management Info
Ashish Dandekar - Chairman N Momaya - Managing Director
Registered Office

Address Floor 2 to 5 Building in G S Point,Plot No. V I I I, Private Layout Scheme,Opp. University Campus, C. S. T. Road,  Kalina, Santacruz (East),
Mumbai,
Maharashtra-400098

Phone 022-67001000

Email corporate@camlinfs.com / secretarial@camlinfs.com

Website www.camlinfs.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

28May Camlin Fine Sciences informs about s
Pursuant to regulation 24A of SEBI (Listing Obligations and Disclosure R..
08May Camlin Fine Sciences informs about vot
In furtherance to letter dated April 7, 2026, for seeking consent of the..
10Apr Camlin fine Sciences informs about dis
Camlin fine Sciences has informed that the exchange has received the Dis..
18Mar Camlin Fine Sciences informs about di
Camlin Fine Sciences has informed that the exchange has received Disclos..
17Mar Camlin Fine Sciences informs about pre
In continuation of its previous intimations to the stock exchanges regar..

Financials

in Millions
QTR Mar 26 ANNUAL 26
Net Profit-56.4999999999998-329.679999999999
Gross Profit -166.37 -540.939999999999
Operating Profit 213.1828.400000000001
Net Sales 1835.178379.18

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Elantas Beck India (BSE)
peergroup  9972.40 (1.60%)
M.Cap ( in Cr)7905.80
Foseco India (BSE)
peergroup  5224.55 (2.77%)
M.Cap ( in Cr)3937.88
Fine Organic Inds. (BSE)
peergroup  5035.25 (2.35%)
M.Cap ( in Cr)15438.06
Premier Explosives (BSE)
peergroup  738.15 (8.03%)
M.Cap ( in Cr)3968.38
Tanfac Industries (BSE)
peergroup  2117.00 (2.44%)
M.Cap ( in Cr)4223.42

Shareholding Pattern

MUTUAL FUNDS/UTI 6.8%
PROMOTERS 48.03%
NON-INSTITUTION 43.33%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Camlin Fine Sciences Ltd.

Camlin Fine Sciences Ltd. was incorporated in the year 1993. Its today's share price is 138.25. Its current market capitalisation stands at Rs 2655.74 Cr. In the latest quarter, company has reported Gross Sales of Rs. 8864.91 Cr and Total Income of Rs.9075.43 Cr. The company's management includes Rahul Sawale, Mahabaleshwar G Palekar, Arjun S Dukane, Anagha S Dandekar, Abeezar Faizullabhoy, Pradip Kanakia, Jens Van Nieuwenborgh, Joseph Conrad D' Souza, N Momaya, Radhika Dudhat, Amol Shah, Harsha Raghavan, Ashish Dandekar, Ashish Dandekar.

It is listed on the BSE with a BSE Code of 532834 , NSE with an NSE Symbol of CAMLINFINE and ISIN of INE052I01032. It's Registered office is at Floor 2 to 5 Building in G S Point,Plot No. V I I I, Private Layout Scheme,Opp. University Campus, C. S. T. Road,  Kalina, Santacruz (East)Mumbai-400098, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BK Khare & Co, Kalyaniwalla & Mistry LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.